JK&B Capital

About

Portfolio · 4

EarlySense

Contact-free Continuous Monitoring Solutions

5 rounds $106.0M committed Latest: 2019-01

Pharma Two B

Innovative Combinations of Previously Approved Drugs

2 rounds $38.0M committed Latest: 2017-02

Viewfinity

Local Administrator Privilege Management

2 rounds $17.5M committed Latest: 2012-09

EZChip

Fabless Manufacturer of Network Processors and Semiconductors

1 round $13.5M committed Latest: 2003-03

Investment activity

2 portfolio exits on record.

Q&A

What is JK&B Capital's primary investment focus?

JK&B Capital focuses on software, IT, and communications markets. The firm was founded in 1996 and manages over $1.1 billion in assets.

Can you name some of JK&B Capital's notable portfolio companies?

JK&B Capital's portfolio includes EarlySense, which provides contact-free continuous monitoring solutions, and Pharma Two B, which develops innovative combinations of previously approved drugs.

What are some of JK&B Capital's significant exits?

JK&B Capital had a notable exit in February 2016 with the acquisition of EZChip by Mellanox Technologies for $810 million. Another exit was the acquisition of Viewfinity by CyberArk for $30 million in October 2015.

What is JK&B Capital's approach to investment decisions?

JK&B Capital takes a team-based approach to investment decisions and typically leads funding rounds, providing financial support, strategic guidance, and hands-on technical assistance to its portfolio companies.

Which sectors has JK&B Capital shown concentration in for its portfolio companies?

JK&B Capital's portfolio companies are concentrated in Health Tech & Life Sciences and Cyber Security.

What is the typical investment range for JK&B Capital?

JK&B Capital's investment range is between $7 million and $39 million.

When was JK&B Capital founded?

JK&B Capital was founded in 1996.